CLINICAL SIGNIFICANCE OF CASPASE-3 EXPRESSION IN PATHOLOGIC-STAGE I, NONSMALL-CELL LUNG CANCER

被引：0
|
作者：
Jiang, Dong [1 ]
Zheng, Shiying [1 ]
Li, Hong [2 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Dept Geriatr, Suzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
caspase-3; Prognosis; Lung cancer; apoptosis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1247 / S1248
页数：2
相关论文
共 50 条
  • [41] Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study
    Li, Hong
    Zhou, Ren-Jie
    Zhang, Guo-Qiang
    Xu, Jian-Ping
    TUMOR BIOLOGY, 2013, 34 (03) : 1807 - 1812
  • [42] Poor survival for veterans with pathologic stage I non-small-cell lung cancer
    St Julien, Jamii B.
    Pinkerman, Rhonda
    Aldrich, Melinda C.
    Chen, Heidi
    Deppen, Stephen A.
    Callaway-Lane, Carol
    Massion, Pierre
    Putnam, Joe B.
    Lambright, Eric S.
    Nesbitt, Jonathan C.
    Grogan, Eric L.
    AMERICAN JOURNAL OF SURGERY, 2012, 204 (05) : 637 - 642
  • [43] Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions
    Cooper, Wendy A.
    Kohonen-Corish, Maija R. J.
    Zhuang, Liqing
    McCaughan, Brian
    Kennedy, Catherine
    Screaton, Gavin
    Sutherland, Robert L.
    Lee, C-Soon
    CANCER, 2008, 113 (01) : 135 - 142
  • [44] Stage I Nonsmall Cell Lung Cancer in Patients Aged ≥75 Years Outcomes After Stereotactic Radiotherapy
    Haasbeek, Cornelis J. A.
    Lagerwaard, Frank J.
    Antonisse, Marilisa E.
    Slotman, Ben J.
    Senan, Suresh
    CANCER, 2010, 116 (02) : 406 - 414
  • [45] Higher Expression of Chemokine Receptor CXCR7 Is Linked to Early and Metastatic Recurrence in Pathological Stage I Nonsmall Cell Lung Cancer
    Iwakiri, Shotaro
    Mino, Nobuya
    Takahashi, Tsuyoshi
    Sonobe, Makoto
    Nagai, Shinjiro
    Okubo, Kenichi
    Wada, Hiromi
    Date, Hiroshi
    Miyahara, Ryo
    CANCER, 2009, 115 (11) : 2580 - 2593
  • [46] Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer
    Shibamoto, Yuta
    Hashizume, Chisa
    Baba, Fumiya
    Ayakawa, Shiho
    Manabe, Yoshihiko
    Nagai, Aiko
    Miyakawa, Akifumi
    Murai, Taro
    Iwata, Hiromitsu
    Mori, Yoshimasa
    Mimura, Mikio
    Ishikura, Satoshi
    CANCER, 2012, 118 (08) : 2078 - 2084
  • [47] Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer
    Zhu, Junfei
    Zhang, Youlin
    Yang, Xi
    Jin, Litong
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2017, 32 (04) : 115 - 123
  • [48] A histone deacetylase inhibitor enhances expression of genes inhibiting Wnt pathway and augments activity of DNA demethylation reagent against nonsmall-cell lung cancer
    Shieh, Jiunn-Min
    Tang, Yen-An
    Hu, Fu-Han
    Huang, Wei-Jan
    Wang, Ying-Jan
    Jen, Jayu
    Liao, Sheng-You
    Lu, Ying-Hung
    Yeh, Ya-Ling
    Wang, Tseng-Wei
    Lin, Pinpin
    Wang, Yi-Ching
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (10) : 2375 - 2386
  • [49] Expression patterns of miR-221 and its target Caspase-3 in different cancer cell lines
    Ergun, Sercan
    Arman, Kaifee
    Temiz, Ebru
    Bozgeyik, Ibrahim
    Yumrutas, Onder
    Safdar, Muhammad
    Dagli, Hasan
    Arslan, Ahmet
    Oztuzcu, Serdar
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (09) : 5877 - 5881
  • [50] Prognostic significance of thrombomodulin expression and vascular invasion in stage I squamous cell carcinoma of the lung
    Tamura, A
    Hebisawa, A
    Hayashi, K
    Sagara, Y
    Fukushima, K
    Kurashima, A
    Yotsumoto, H
    Mori, M
    Komatsu, H
    LUNG CANCER, 2001, 34 (03) : 375 - 382
12345